Clinical Trial Update: Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating blood-brain barrier disruption with Exablate focused ultrasound to enhance delivery of doxorubicin for pediatric diffuse int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: InSightec | Conditions: Brain Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING